Ghodhbane Hanen, Elaidi Sabrine, Sabatier Jean-Marc, Achour Sami, Benhmida Jeannette, Regaya Imed
Higher Institute of Environmental Sciences and Technologies of Borj Cedria, University of Carthage, 1003 Hammam Lif, Tunisia.
Infect Disord Drug Targets. 2015;15(1):2-12. doi: 10.2174/1871526514666140522113337.
Multiresistant Gram-negative bacteria are the prime mover of nosocomial infections. Some are naturally resistant to antibiotics, their genetic makes them insensitive to certain families of antibiotics and they transmit these resistors to their offspring. Moreover, when bacteria are subjected to antibiotics, they eventually develop resistance against drugs to which they were previously sensitive. In recent years, many bacteriocins active against gram-negative bacteria have been identified proving their efficacy in treating infections. While further investigation remains necessary before the possibilities for bacteriocins in clinical practice can be described more fully, this review provides an overview of bacteriocins acting on the most common infectious gram negative bacteria (Klebsiella, Acinetobacter, Pseudomonas aeruginosa and E. coli).
多重耐药革兰氏阴性菌是医院感染的主要推动者。有些细菌天生就对抗生素具有耐药性,它们的基因使它们对某些抗生素家族不敏感,并将这些耐药基因传递给后代。此外,当细菌接触抗生素时,它们最终会对以前敏感的药物产生耐药性。近年来,已鉴定出许多对革兰氏阴性菌有活性的细菌素,证明了它们在治疗感染方面的功效。虽然在更全面地描述细菌素在临床实践中的应用可能性之前仍有必要进行进一步研究,但本综述概述了作用于最常见的感染性革兰氏阴性菌(克雷伯菌、不动杆菌、铜绿假单胞菌和大肠杆菌)的细菌素。